Nocardiosis: a review.
Infections caused by Nocardia species are infrequent but challenging to clinicians. They cause a wide variety of diseases in both normal and immunocompromised patients. In recent years, the number of case reports has been increasing, and this can be attributed to the improvements in diagnostic capabilities and the higher clinical index of suspicion accompanying the increased prevalence of immunosuppressed patients. The treatment of nocardiosis also requires expertise. This report reviews the epidemiology, physiopathology, clinical manifestations, diagnosis and treatment of this aerobic bacterial disease.
Corti
Marcelo E
ME
Unit 10, Infectious Diseases, FJ Muñiz Hospital, Buenos Aires, Argentina. marcelocorti@ciudad.com.ar
Villafañe-Fioti
María F
MF
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D020806:Central Nervous System Bacterial Infections / Q000175:diagnosis / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D008875:Middle Aged; D009615:Nocardia; D009617:Nocardia Infections / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D009894:Opportunistic Infections; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000382:microbiology / Q000473:pathology / Q000628:therapy
D000900:Anti-Bacterial Agents